PHARMA NORD EXPORT ApS: Financial statements 2022
CVR: 70996510
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PHARMA NORD EXPORT ApS (CVR 70996510) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,614,118 and a net result of DKK 2,109,599 compared with DKK 3,174,436 the year before. That is a decrease of 5.1% compared with the year before. Equity in the 2022 report amounted to DKK 46,048,337. The solvency ratio was 69.1%. The company had 63 employees in the financial year.
- Gross Profit
- DKK 1,614,118
- Profit/Loss
- DKK 2,109,599
- Equity
- DKK 46,048,337
- Total Assets
- DKK 66,671,354
- Employees
- 63
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.6 mio. | 2.1 mio. | 46 mio. | 63 |
| 2021 | - | 1.7 mio. | 3.2 mio. | 43.9 mio. | 49 |
| 2020 | - | 2.2 mio. | 2.7 mio. | 40.8 mio. | 48 |
| 2019 | - | 2 mio. | -583 t. | 73.1 mio. | - |
| 2018 | - | 2.1 mio. | 4.3 mio. | 69.8 mio. | - |
Official annual report
Keep an eye on PHARMA NORD EXPORT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PHARMA NORD EXPORT ApS has published its annual report for 2021. Gross profit came to DKK 1,701,567, and the net result was DKK 3,174,436.
About PHARMA NORD EXPORT ApS
PHARMA NORD EXPORT ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1982. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named TRAUDE SCHNEIDER ASTROFAKTA-DANMARK ApS. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO II ApS and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK 1,575,000 and a net result of DKK 11,516,000 compared with DKK 6,889,205 the year before. Equity in the 2025 report amounted to DKK 46,928,000.